Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (141-150 of 273) with videos related to

Pageof 28
Sort By:
Blood Advances|January 4, 2018
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokinesYanyan Zhang, Liang He, Dorothée Selimoglu-Buet, et al.
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.
Blood|August 31, 2011
Fine-tuning nucleophosmin in macrophage differentiation and activationLeslie Guery, Naïma Benikhlef, Thomas Gautier, et al.
Blood|June 10, 2004
Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated eventStéphanie Plenchette, Séverine Cathelin, Cédric Rébé, et al.
The Journal of Clinical Investigation|October 3, 2008
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancerStephan Roux, Lionel Apetoh, Fanny Chalmin, et al.
Science Signaling|October 19, 2017
Resveratrol stimulates the metabolic reprogramming of human CD4<sup>+</sup> T cells to enhance effector functionMarco Craveiro, Gaspard Cretenet, Cédric Mongellaz, et al.
Cancer Research|April 17, 2004
Increased immunogenicity of colon cancer cells by selective depletion of cytochrome CElise Schmitt, Arnaud Parcellier, François Ghiringhelli, et al.
Blood|June 15, 2017
Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMMLDorothée Selimoglu-Buet, Bouchra Badaoui, Emmanuel Benayoun, et al.
The Journal of Clinical Investigation|January 17, 2014
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivationDominique Bluteau, Alessandra Balduini, Nathalie Balayn, et al.
Nature Communications|November 8, 2022
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemiaAwatef Allouch, Laurent Voisin, Yanyan Zhang, et al.
Pageof 28

Showing results (141-150 of 273) with videos related to

Sort By:
Pageof 28
Blood Advances|January 4, 2018
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokinesYanyan Zhang, Liang He, Dorothée Selimoglu-Buet, et al.
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.
Blood|August 31, 2011
Fine-tuning nucleophosmin in macrophage differentiation and activationLeslie Guery, Naïma Benikhlef, Thomas Gautier, et al.
Blood|June 10, 2004
Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated eventStéphanie Plenchette, Séverine Cathelin, Cédric Rébé, et al.
The Journal of Clinical Investigation|October 3, 2008
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancerStephan Roux, Lionel Apetoh, Fanny Chalmin, et al.
Science Signaling|October 19, 2017
Resveratrol stimulates the metabolic reprogramming of human CD4<sup>+</sup> T cells to enhance effector functionMarco Craveiro, Gaspard Cretenet, Cédric Mongellaz, et al.
Cancer Research|April 17, 2004
Increased immunogenicity of colon cancer cells by selective depletion of cytochrome CElise Schmitt, Arnaud Parcellier, François Ghiringhelli, et al.
Blood|June 15, 2017
Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMMLDorothée Selimoglu-Buet, Bouchra Badaoui, Emmanuel Benayoun, et al.
The Journal of Clinical Investigation|January 17, 2014
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivationDominique Bluteau, Alessandra Balduini, Nathalie Balayn, et al.
Nature Communications|November 8, 2022
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemiaAwatef Allouch, Laurent Voisin, Yanyan Zhang, et al.
Pageof 28